HD-OPM Archive
Hashtags

#stemcells

22 posts

Mutated blood stem cells (CHIP) may be a major cause of heart disease, doubling MI risk

Apr 08, 2024 · Louis Nervegna ♥ 14 · 💬 13 Inflammation & CRP

Louis explains clonal hematopoiesis (CHIP): age-related mutations in bone-marrow stem cells yield white blood cells that drive inflammation and plaque growth, and the same mutations link to leukemia. A quoted report says CHIP carriers had a 54% higher chance of dying within a decade, from heart attacks and strokes, and mouse transplants of CHIP-mutated cells produced fast-growing, inflamed plaques. Louis credits Gokhan Can for pointing him to this.

Aging stem cells open a direct platelet pathway that raises thrombosis risk (Cell 2024)

Jun 09, 2024 · Gokhan Can ♥ 5 · 💬 12 Heart attack, stroke & procedures

Shares the abstract of a Cell paper showing that with age, hematopoietic stem cells increasingly make platelets through a direct route that bypasses the usual progenitor cascade. The platelets from this pathway are more prone to thrombosis and cause higher platelet counts. It offers a possible cellular explanation for why clotting-related cardiovascular disease rises so steeply in older people.

Cholesterol as a master regulator of blood stem cells, driving inflammatory hematopoiesis

Oct 19, 2025 · Gokhan Can ♥ 7 · 💬 4 Inflammation & CRP

Review of preclinical evidence that high LDL pulls hematopoietic stem cells out of dormancy, causing proliferation, oxidative stress, telomere shortening, impaired repopulation and lasting epigenetic changes that program blood and immune cells toward chronic inflammation. This offers a molecular basis for residual inflammatory risk after cholesterol is treated.

Reprogrammed stem-cell islet transplant freed a woman with type 1 diabetes from insulin

Sep 28, 2024 · Louis Nervegna ♥ 10 · 💬 6 Insulin resistance & diabetes

Shared from Luigi Fontana: a 25-year-old woman with type 1 diabetes received autologous chemically induced pluripotent stem cell islets under the abdominal rectus sheath. She stopped needing insulin within 2.5 months, with time-in-range rising from 43.18% to 96.21% by month 4 and above 98% afterward (HbA1c about 5%). At 1 year all endpoints were met with no transplant-related issues. A single patient, and about type 1 not cardiovascular disease.

Vitamin C slowed bone marrow aging in monkeys in a 3-year trial

Jul 23, 2026 · Louis Nervegna ♥ 6 · 💬 2 Aging & longevity

A 3+ year trial in aged cynomolgus monkeys found oral vitamin C partly offset bone marrow aging, expanding common lymphoid progenitors and rebalancing lineage output, with about a 4-year reduction in transcriptomic age estimates. Louis notes bone marrow stem cell decline contributes to aging and heart disease.

Stem-cell heart patch (BioVAT) raised ejection fraction at 3 months in phase 1-2 trial

Jun 20, 2026 · Louis Nervegna ♥ 6 · 💬 1 Heart rhythm & heart failure

Louis shares a NEJM interim report of a phase 1-2 trial in which stem-cell-derived engineered tissue was placed on the surface of failing human hearts. At 3 months it was associated with thicker target heart wall, higher ejection fraction and better quality-of-life scores, though every patient had at least one adverse event and longer follow-up is needed.

Bone marrow stem cells are limited by telomere shortening, not immortal

Jul 22, 2026 · Louis Nervegna ♥ 4 · 💬 1 Aging & longevity

Louis explains that bone marrow stem cells, which renew blood and help repair tissue including the heart, cannot divide indefinitely because of telomere shortening. He shares a study showing telomeric DNA damage signaling drives hematopoietic aging, and inhibiting it restored function in mice and human stem cells.